{"version":"1.0","type":"link","title":"Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.","author_name":"Dent R 외","author_url":"https://prs-insight.online/author/Dent%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/77569","thumbnail_width":1200,"thumbnail_height":630}